Top News
Latest News
PARTNERSHIPS
13 Jan 2026
AI Alliance Refines RNA Cancer Drug DiscoveryINVESTMENT
12 Jan 2026
A New Pulse in Biotech IPOs Starts With OncologyTECHNOLOGY
7 Jan 2026
Can Generative AI Crack the Code of mRNA Design?RESEARCH
19 Dec 2025
A New Twist Makes mRNA Drugs More Selective
BARDA Pullback Signals New Phase for US mRNA Development
REGULATORY
18 Dec 2025
HHS is winding down BARDA-backed mRNA vaccine programs, prompting analysts to see a shift toward commercially focused mRNA strategies
PARTNERSHIPS
13 Jan 2026
AI Alliance Refines RNA Cancer Drug Discovery
Oncovita teams with Infinitusbio.AI to use digital cell modeling to sharpen early decisions in RNA oncology research
INVESTMENT
12 Jan 2026
A New Pulse in Biotech IPOs Starts With Oncology
Aktis Oncology’s planned Nasdaq debut, backed by Eli Lilly, suggests investors are cautiously returning to targeted cancer innovation
TECHNOLOGY
7 Jan 2026
Can Generative AI Crack the Code of mRNA Design?
New preclinical data suggest generative AI could streamline mRNA design and reduce costly trial-and-error for future therapies
RESEARCH
19 Dec 2025
A New Twist Makes mRNA Drugs More Selective
Preclinical US research in mouse models suggest redesigned mRNA activates mainly in diseased cells, hinting at safer drugs as human trials...
REGULATORY
18 Dec 2025
BARDA Pullback Signals New Phase for US mRNA Development
HHS is winding down BARDA-backed mRNA vaccine programs, prompting analysts to see a shift toward commercially focused mRNA strategies
INNOVATION
17 Dec 2025
mRNA Design Enters a More Predictive Era
New AI research forecasts mRNA protein output earlier, helping developers refine drug designs before costly lab testing begins
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.